Components of gut bacteria as immunomodulators.
暂无分享,去创建一个
H. Flad | A. Ulmer | E. Rietschel | V. El-Samalouti | L. Hamann | Artur J. Ulmer | Lutz Hamann | E. Rietschel
[1] F. Meng,et al. Lipopolysaccharide (LPS)-induced Macrophage Activation and Signal Transduction in the Absence of Src-Family Kinases Hck, Fgr, and Lyn , 1997, The Journal of experimental medicine.
[2] T. van der Poll,et al. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. , 1997, Journal of immunology.
[3] P. Ferrara,et al. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. , 1997, Journal of immunology.
[4] Jiahuai Han,et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.
[5] H. Flad,et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes , 1997, Infection and immunity.
[6] H. Flad,et al. Lipopolysaccharide‐binding protein mediates CD14‐independent intercalation of lipopolysaccharide into phospholipid membranes , 1996, FEBS letters.
[7] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[8] R. Dziarski,et al. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. , 1996, The Journal of infectious diseases.
[9] T. Kirkland,et al. CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.
[10] A. DeFranco,et al. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] Yi-Ping Jin,et al. Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. , 1995, Journal of immunology.
[12] T. Hunter,et al. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus , 1995, Current Biology.
[13] H. Flad,et al. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein , 1995, Infection and immunity.
[14] D. Golenbock,et al. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide , 1995, The Journal of experimental medicine.
[15] M. Kelley,et al. Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64 (*) , 1995, The Journal of Biological Chemistry.
[16] M. Ernst,et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14 , 1995, Infection and immunity.
[17] C. Eckerskorn,et al. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants , 1995, European journal of immunology.
[18] H. Flad,et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures , 1994, Infection and immunity.
[19] N. Reiner,et al. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. , 1994, Journal of immunology.
[20] M. Wurfel,et al. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS , 1994, The Journal of experimental medicine.
[21] M. Glauser,et al. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Randolph,et al. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. , 1994, The Journal of biological chemistry.
[23] Y. Uehara,et al. Lipopolysaccharide‐induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transduction , 1994, European journal of immunology.
[24] E. Vellenga,et al. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human monocytes. A study of the molecular mechanisms involved in inflammatory cytokine expression. , 1994, The Journal of biological chemistry.
[25] T. Kirikae,et al. Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] R. Ulevitch,et al. Recognition of endotoxin by cells leading to transmembrane signaling. , 1994, Current opinion in immunology.
[27] K. Takayama,et al. Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. , 1994, The Journal of biological chemistry.
[28] M. Lotz,et al. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. , 1993, Journal of immunology.
[29] H. Northoff,et al. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I , 1993, Infection and immunity.
[30] R. Ulevitch,et al. Analysis of lipopolysaccharide binding by CD14. , 1993, The Journal of biological chemistry.
[31] M. Freeman,et al. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. , 1993, The Journal of biological chemistry.
[32] R. Davis,et al. The mitogen-activated protein kinase signal transduction pathway. , 1993, The Journal of biological chemistry.
[33] M. Read,et al. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. , 1993, The Journal of biological chemistry.
[34] M. Kastowsky,et al. Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide. , 1993, Immunobiology.
[35] P. Baeuerle,et al. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. , 1993, Immunobiology.
[36] R. Ulevitch,et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Akira,et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Skjåk‐Braek,et al. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers , 1993, European journal of immunology.
[39] B. Finlay,et al. Soluble CD14 participates in the response of cells to lipopolysaccharide , 1992, The Journal of experimental medicine.
[40] Wendy L. Freedman,et al. THE EXPANSION RATE AND SIZE OF THE UNIVERSE , 1992 .
[41] R. Ulevitch,et al. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14- mediated pathway , 1992, The Journal of experimental medicine.
[42] A. DeFranco,et al. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. , 1992, The Journal of biological chemistry.
[43] K. Kato,et al. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein , 1992, The Journal of experimental medicine.
[44] I. Azuma. Review: inducer of cytokines in vivo: overview of field and romurtide experience. , 1992, International journal of immunopharmacology.
[45] Alan D. Roberts,et al. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor , 1992, Infection and immunity.
[46] A. R. Nogare,et al. Southwestern Internal Medicine Conference: Septic Shock , 1991 .
[47] R. Dziarski. Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. , 1991, The Journal of biological chemistry.
[48] J. Höltje,et al. Isolation and separation of the glycan strands from murein of Escherichia coli by reversed-phase high-performance liquid chromatography. , 1990, Analytical biochemistry.
[49] R. Ulevitch,et al. Structure and function of lipopolysaccharide binding protein. , 1990, Science.
[50] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[51] R. Strieter,et al. Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression , 1989, Infection and immunity.
[52] A. Waage,et al. Cytokine regulation of interleukin 6 production by human endothelial cells. , 1989, Cellular immunology.
[53] J. Maller,et al. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.
[54] U. Schwarz,et al. The composition of the murein of Escherichia coli. , 1988, The Journal of biological chemistry.
[55] R. Cotran,et al. Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[56] H. Friedman,et al. Immunobiology and Immunopharmacology of Bacterial Endotoxins , 1987 .
[57] C. Nathan,et al. Secretory products of macrophages. , 1987, The Journal of clinical investigation.
[58] W. J. Cromartie,et al. Acute And Chronic Inflammation Induced By Peptidoglycan Structures And Polysaccharide Complexes , 1986 .
[59] S. Wright,et al. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide , 1986, The Journal of experimental medicine.
[60] A. Tanaka,et al. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. , 1986, Federation proceedings.
[61] E. Rietschel,et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. , 1985, European journal of biochemistry.
[62] E. Günther,et al. Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection , 1977, Infection and immunity.
[63] R. Menzel,et al. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. , 1997, European journal of biochemistry.
[64] R R Schumann,et al. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. , 1996, Current topics in microbiology and immunology.
[65] P. Brandtzaeg. Significance and pathogenesis of septic shock. , 1996, Current topics in microbiology and immunology.
[66] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[67] B. Lindner,et al. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. , 1994, Advances in carbohydrate chemistry and biochemistry.
[68] H. Loppnow. LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms. , 1994, Progress in clinical and biological research.
[69] J. Rüschoff,et al. The role of TNF in tumour growth and metastasis. , 1993, Research in immunology.
[70] S. Wright,et al. Multiple receptors for endotoxin. , 1991, Current opinion in immunology.
[71] E. Schrinner. Surface structures of microorganisms and their interactions with the mammalian host , 1988 .
[72] W. J. Cromartie,et al. Lipopolysaccharide-Induced Recurrence of Arthritis Initiated by Peptidoglycan-Polysaccharide , 1986 .
[73] E. Mihich. Immunological approaches to cancer therapeutics , 1982 .